Tale of a hero for generations of Air Warriors: Flying Officer Nirmal Jit Singh Shekhon

Flying Officer Nirmal Jit Singh Shekhon was commissioned into the No. 18 Squadron, known as “Flying Bullets” in Oct 1968. The squadron was known so because of their incredible skill to maneuver in the air. 1971 was a year when the Indo-Pak border had become a battlefield. Flying officer Shekhon was a pilot of the … Continue reading Tale of a hero for generations of Air Warriors: Flying Officer Nirmal Jit Singh Shekhon

Assessing the Hits and Misses of Social Media on this Social Media Day

June 30 is commemorated as World Social Media day Social Media has become an integral part of our lives. Agree? However, the COVID-19 pandemic has made us realize the importance of social media like never before. At these unprecedented times of nationwide lockdowns, home quarantines, and physical distancing, social media is playing a vital role … Continue reading Assessing the Hits and Misses of Social Media on this Social Media Day

Surviving a Relationship during the COVID-19 Pandemic

When the lockdown was announced, a lot of couples staying together felt blessed and thought they were in some long-drawn honeymoon. However, staying together 24/7 is bringing up a lot of challenges to the fore. Disturbing loud meetings, taxing internet bandwidths, uneven distribution of chores are leaving people flustered and a bit frustrated. How can … Continue reading Surviving a Relationship during the COVID-19 Pandemic

‘Patient-first, Science Based Regulatory Approaches for Insulins’

Dr. Sundar Ramanan, VP, Global Regulatory Affairs, Biocon, Presented at the U.S. FDA Public Hearing on Increasing Insulins Access Biocon Ltd. was among a handful of biopharmaceutical companies that presented at the U.S. Food and Drug Administration’s (FDA) public hearing “The Future of Insulin Biosimilars: Increasing Access and Facilitating the Efficient Development of Biosimilar and … Continue reading ‘Patient-first, Science Based Regulatory Approaches for Insulins’

Biocon’s Differentiated Innovation Story Beginning to Pay Off

Biocon’s biopharma journey took off on a differentiated path fraught with challenges.  In the late 90’s when we started the prevailing business ethos in pharmaceutical sector favored a predictable and attractive ROCE (Return On Capital Employed) ventures based on chemically synthesized generic drugs. Biocon, however, chose to invest in developing biologic drugs based on recombinant … Continue reading Biocon’s Differentiated Innovation Story Beginning to Pay Off